Omeros (NASDAQ:OMER) Given Buy Rating at D. Boral Capital
D. Boral Capital reissued their buy rating on shares of Omeros (NASDAQ:OMER – Free Report) in a research report report published on Friday morning,Benzinga reports. D. Boral Capital currently has a $36.00 target price on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the company. StockNews.com downgraded […]
D. Boral Capital reissued their buy rating on shares of Omeros (NASDAQ:OMER – Free Report) in a research report report published on Friday morning,Benzinga reports. D. Boral Capital currently has a $36.00 target price on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the company. StockNews.com downgraded […]
